查看购物车
  • Traditional Chinese
  • English
封面
市场调查报告书
商品编码
1685214

心电图 (ECG) 设备市场机会、成长动力、产业趋势分析与预测 2025 - 2034

Electrocardiogram (ECG) Devices Market Opportunity, Growth Drivers, Industry Trend Analysis, and Forecast 2025 - 2034
出版日期: | 出版商: Global Market Insights Inc. | 英文 158 Pages | 商品交期: 2-3个工作天内

价格
简介目录

2024 年全球心电图设备市场价值为 77 亿美元，预计 2025 年至 2034 年的复合年增长率为 4.2%。心臟病、心律不整和高血压等心血管疾病仍是全球主要的健康挑战，推动了对心电图设备的需求。这些疾病是全球主要死亡原因之一，凸显了早期发现和持续监测的必要性。人口老化更容易出现心臟相关併发症，在推动市场成长方面发挥重要作用。

心电图 (ECG) 设备市场 - IMG1

世界各国政府都将心血管疾病的早期发现和管理放在首位，同时增加医疗支出以支持先进医疗技术的发展。人们对心臟健康的认识也日益增强，促使人们转向预防保健和定期心臟检查。心电图设备的不断进步，例如增强的数位连接和改进的诊断演算法，使其在各种医疗保健环境中（包括医院、诊断中心和家庭医疗保健）越来越容易使用和有效。更广泛的可用性和增强的功能是市场扩张的主要驱动力。

市场范围
起始年份 2024
预测年份 2025-2034
起始值 77亿美元
预测值 116亿美元
复合年增长率 4.2％

就产品类型而言，心电图设备市场主要分为诊断心电图机和监测心电图设备。诊断性心电图机器市场预计将以 3.7% 的复合年增长率成长，到 2034 年将达到 61 亿美元。这些机器在检测心臟异常方面发挥着至关重要的作用，使医疗保健提供者能够高精度地评估心臟活动。与老化相关的慢性病发生率不断上升是推动诊断机器需求的重要因素。同时，多导线配置和数位整合等持续的技术改进正在提高其在临床环境中的效率和准确性，简化工作流程并改善患者的治疗效果。

依导联类型细分，心电图设备市场分为单导极、3 导联、6 导联、12 导联和其他导联类型。 12 导程心电图市场表现突出，预计复合年增长率为 4.7%，到 2034 年将达到 53 亿美元。该市场因其全面评估心臟活动的能力而占据主导地位，对于诊断复杂的心血管疾病必不可少。医疗保健专业人员高度依赖 12 导程心电图的准确性和心律详细分析，尤其是在紧急和重症监护环境中。这些设备对于重症监护室和心臟监测中心至关重要，因为它们具有广泛的诊断能力，可确保精确监测心臟健康。

在美国，心电图设备市场在 2024 年的价值为 24 亿美元，预计到 2034 年的复合年增长率为 3.8%。心血管疾病的持续高发生率继续推动对心电图设备的需求，因为早期诊断和持续监测对于管理心臟病至关重要。美国正在经历人口老化，更容易罹患慢性心臟病，进一步刺激市场需求。凭藉强大的医疗保健基础设施和持续的技术进步，美国有能力引领全球市场。随着对创新心电图解决方案的投资增加和患者意识的提高，美国市场将在未来几年继续成长。

目录

第 1 章：方法论与范围

第 2 章：执行摘要

第 3 章：产业洞察

  • 产业生态系统分析
  • 产业衝击力
    • 成长动力
      • 心血管疾病盛行率不断上升
      • 心电图设备的技术进步
      • 行动和遥测心臟监视器的普及率不断提高
      • 心臟健康意识不断增强
    • 产业陷阱与挑战
      • 先进心电图设备成本高昂
      • 缺乏熟练的专业人员
  • 成长潜力分析
  • 监管格局
  • 技术格局
  • 差距分析
  • 波特的分析
  • PESTEL 分析
  • 未来市场趋势
  • 穿戴式心电图设备对阵发性心臟相关症状患者实用性的概述
  • 临床环境下手持式心电图设备的开发
  • 用于运动时心电图监测的柔性穿戴电极的开发

第四章：竞争格局

  • 介绍
  • 公司矩阵分析
  • 公司市占率分析
  • 主要市场参与者的竞争分析
  • 竞争定位矩阵
  • 策略仪表板

第五章：市场估计与预测：按产品，2021 — 2034 年

  • 主要趋势
  • 诊断心电图机
    • 静止心电图
    • 压力心电图
  • 监测心电图设备
    • 动态心电图监测
    • ECG遥测监测/事件监测
    • 植入式心臟监测仪
    • 其他监测心电图设备

第六章：市场估计与预测：依线索类型，2021 年至 2034 年

  • 主要趋势
  • 单引线型
  • 3 引线类型
  • 6 引线类型
  • 12 引线型
  • 其他引线类型

第 7 章：市场估计与预测：按便携性，2021 年至 2034 年

  • 主要趋势
  • 非便携式设备
  • 便携式设备

第 8 章：市场估计与预测：依最终用途，2021 年至 2034 年

  • 主要趋势
  • 医院和诊所
  • 门诊手术中心
  • 诊断中心
  • 居家照护环境
  • 其他最终用户

第 9 章：市场估计与预测：按地区，2021 年至 2034 年

  • 主要趋势
  • 北美洲
    • 我们
    • 加拿大
  • 欧洲
    • 德国
    • 英国
    • 法国
    • 西班牙
    • 义大利
    • 荷兰
  • 亚太地区
    • 中国
    • 日本
    • 印度
    • 澳洲
    • 韩国
  • 拉丁美洲
    • 巴西
    • 墨西哥
    • 阿根廷
  • 中东和非洲
    • 南非
    • 沙乌地阿拉伯
    • 阿联酋

第十章：公司简介

  • ALIVECOR
  • Allengers
  • biotricity
  • bionet
  • BIOTRONIK
  • Boston Scientific
  • BPL Medical Technologies
  • CARDIOLINE
  • FUKUDA
  • GE HealthCare
  • Baxter
  • PHILIPS
  • Medtronic
  • mindray
  • SPACELABS HEALTHCARE
简介目录
Product Code: 5425

The Global Electrocardiogram Devices Market, valued at USD 7.7 billion in 2024, is expected to expand at a CAGR of 4.2% from 2025 to 2034. Cardiovascular diseases, including heart attacks, arrhythmias, and hypertension, continue to be major health challenges worldwide, driving the demand for ECG devices. These conditions are among the leading causes of death globally, highlighting the need for early detection and continuous monitoring. The aging population, which is more prone to heart-related complications, plays a significant role in boosting market growth.

Electrocardiogram (ECG) Devices Market - IMG1

Governments worldwide are prioritizing early detection and management of cardiovascular diseases, while healthcare expenditures rise to support the development of advanced medical technologies. There is also growing awareness about heart health, prompting a shift toward preventive care and regular cardiac screenings. Continuous advancements in ECG devices, such as enhanced digital connectivity and improved diagnostic algorithms, are making them increasingly accessible and effective across various healthcare settings, including hospitals, diagnostic centers, and home healthcare. This broader availability and enhanced functionality are key drivers of market expansion.

Market Scope
Start Year2024
Forecast Year2025-2034
Start Value$ 7.7 Billion
Forecast Value$ 11.6 Billion
CAGR4.2%

In terms of product types, the ECG devices market is primarily divided into diagnostic ECG machines and monitoring ECG devices. The diagnostic ECG machines segment is set to grow at a CAGR of 3.7%, reaching USD 6.1 billion by 2034. These machines play a crucial role in detecting cardiac abnormalities, allowing healthcare providers to assess heart activity with high precision. The increasing prevalence of chronic conditions related to aging is a significant factor driving the demand for diagnostic machines. At the same time, continuous technological improvements, such as multi-lead configurations and digital integration, are enhancing their efficiency and accuracy in clinical settings, streamlining workflows and improving patient outcomes.

When broken down by lead type, the ECG devices market is categorized into single-lead, 3-lead, 6-lead, 12-lead, and other lead types. The 12-lead ECG segment stands out, projected to grow at a CAGR of 4.7%, reaching USD 5.3 billion by 2034. This segment dominates due to its comprehensive ability to assess the heart's activity, making it indispensable for diagnosing complex cardiovascular conditions. Healthcare professionals rely heavily on 12-lead ECGs for their accuracy and detailed analysis of heart rhythms, especially in emergency and critical care settings. These devices are vital in intensive care units and cardiac monitoring centers due to their extensive diagnostic capabilities, ensuring precise monitoring of heart health.

In the United States, the ECG devices market was valued at USD 2.4 billion in 2024, with expectations to grow at a CAGR of 3.8% through 2034. The persistent high prevalence of cardiovascular diseases continues to drive the demand for ECG devices, as early diagnosis and continuous monitoring are crucial for managing heart conditions. The U.S. is also witnessing an aging population that is more susceptible to chronic heart diseases, further fueling market demand. With its robust healthcare infrastructure and ongoing technological advancements, the U.S. is well-positioned to lead the global market. As investments in innovative ECG solutions rise and patient awareness improves, the U.S. market is set for continued growth in the coming years.

Table of Contents

Chapter 1 Methodology and Scope

  • 1.1 Market scope and definitions
  • 1.2 Research design
    • 1.2.1 Research approach
    • 1.2.2 Data collection methods
  • 1.3 Base estimates and calculations
    • 1.3.1 Base year calculation
    • 1.3.2 Key trends for market estimation
  • 1.4 Forecast model
  • 1.5 Primary research and validation
    • 1.5.1 Primary sources
    • 1.5.2 Data mining sources

Chapter 2 Executive Summary

  • 2.1 Industry 3600 synopsis

Chapter 3 Industry Insights

  • 3.1 Industry ecosystem analysis
  • 3.2 Industry impact forces
    • 3.2.1 Growth drivers
      • 3.2.1.1 Growing prevalence of cardiovascular diseases
      • 3.2.1.2 Technological advancements in ECG devices
      • 3.2.1.3 Increasing adoption of mobile and telemetry cardiac monitors
      • 3.2.1.4 Rising awareness about heart health
    • 3.2.2 Industry pitfalls and challenges
      • 3.2.2.1 High cost of advanced ECG devices
      • 3.2.2.2 Lack of skilled professionals
  • 3.3 Growth potential analysis
  • 3.4 Regulatory landscape
  • 3.5 Technology landscape
  • 3.6 Gap analysis
  • 3.7 Porter's analysis
  • 3.8 PESTEL analysis
  • 3.9 Future market trends
  • 3.10 Overview on usefulness of wearable ECG devices in patients experiencing paroxysmal cardiac-related symptoms
  • 3.11 Development of a handheld electrocardiogram device in a clinical setting
  • 3.12 Development of flexible wearable electrodes for electrocardiogram monitoring during exercise

Chapter 4 Competitive Landscape, 2024

  • 4.1 Introduction
  • 4.2 Company matrix analysis
  • 4.3 Company market share analysis
  • 4.4 Competitive analysis of major market players
  • 4.5 Competitive positioning matrix
  • 4.6 Strategy dashboard

Chapter 5 Market Estimates and Forecast, By Product, 2021 — 2034 ($ Mn)

  • 5.1 Key trends
  • 5.2 Diagnostics ecg machines
    • 5.2.1 Resting ecg
    • 5.2.2 Stress ecg
  • 5.3 Monitoring ecg devices
    • 5.3.1 Holter monitoring
    • 5.3.2 ECG telemetry monitoring/Event monitoring
    • 5.3.3 Implantable cardiac monitors
    • 5.3.4 Other monitoring ecg devices

Chapter 6 Market Estimates and Forecast, By Lead Type, 2021 — 2034 ($ Mn)

  • 6.1 Key trends
  • 6.2 Single lead type
  • 6.3 3 lead type
  • 6.4 6 lead type
  • 6.5 12 lead type
  • 6.6 Other lead types

Chapter 7 Market Estimates and Forecast, By Portability, 2021 — 2034 ($ Mn)

  • 7.1 Key trends
  • 7.2 Non-portable device
  • 7.3 Portable device

Chapter 8 Market Estimates and Forecast, By End Use, 2021 — 2034 ($ Mn)

  • 8.1 Key trends
  • 8.2 Hospitals and clinics
  • 8.3 Ambulatory surgical centers
  • 8.4 Diagnostic centers
  • 8.5 Home care settings
  • 8.6 Other end users

Chapter 9 Market Estimates and Forecast, By Region, 2021 — 2034 ($ Mn)

  • 9.1 Key trends
  • 9.2 North America
    • 9.2.1 U.S.
    • 9.2.2 Canada
  • 9.3 Europe
    • 9.3.1 Germany
    • 9.3.2 UK
    • 9.3.3 France
    • 9.3.4 Spain
    • 9.3.5 Italy
    • 9.3.6 Netherlands
  • 9.4 Asia Pacific
    • 9.4.1 China
    • 9.4.2 Japan
    • 9.4.3 India
    • 9.4.4 Australia
    • 9.4.5 South Korea
  • 9.5 Latin America
    • 9.5.1 Brazil
    • 9.5.2 Mexico
    • 9.5.3 Argentina
  • 9.6 Middle East and Africa
    • 9.6.1 South Africa
    • 9.6.2 Saudi Arabia
    • 9.6.3 UAE

Chapter 10 Company Profiles

  • 10.1 ALIVECOR
  • 10.2 Allengers
  • 10.3 biotricity
  • 10.4 bionet
  • 10.5 BIOTRONIK
  • 10.6 Boston Scientific
  • 10.7 BPL Medical Technologies
  • 10.8 CARDIOLINE
  • 10.9 FUKUDA
  • 10.10 GE HealthCare
  • 10.11 Baxter
  • 10.12 PHILIPS
  • 10.13 Medtronic
  • 10.14 mindray
  • 10.15 SPACELABS HEALTHCARE